Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 21 July 2000:
Vol. 289. no. 5478, pp. 375 - 377
DOI: 10.1126/science.289.5478.375b
Prev | Table of Contents | Next

News of the Week

ALZHEIMER'S CONGRESS:
Drug Shows Promise for Advanced Disease

Jean Marx

Although the b-amyloid vaccine now being explored as a potential Alzheimer's therapy attracted the bulk of the attention at the World Alzheimer Congress 2000 (see previous story), another, more conventional, drug is showing promise in clinical trials. A neuropsychiatrist reported at the "hot topics" session of the congress that the drug memantine, which has been used in Germany for 10 years to treat dementias, significantly slowed the progression of Alzheimer's symptoms in patients with moderately severe disease.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)